Long-term Follow-up Study of BHC001 for TDT | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long-term Follow-up Study of BHC001 for TDT | stella

Back to Thalassemia, Beta trials

Recruiting

Plain-English translation of NCT06314529 on ClinicalTrials.gov ↗ · Source last updated March 2024 · How we translate trials

Trial locations(2 sites)

China

The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Nanning, Guangxi

Xiangya Hospital of Central South University, Changsha, Hunan

Key details

Sponsor

Bioray Laboratories

Collaborators

The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Xiangya Hospital of Central South University

Enrollment target

~6 participants

Started

December 2022

Primary completion

December 2036

Age range

5 Years – 35 Years

Last updated on clinicaltrials.gov in March 2024.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Xiaochen Wang, PhD

Bioray Laboratories

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.